Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
Zenagamtide for Weight Loss in Adults with Obesity
BelgiumHigh-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency
AustriaA study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity
AustriaA study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
BelgiumStudy of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin
SpainA study to assess the safety of RJVA-001 in adults with type 2 diabetes that is not well controlled by current medications.
The NetherlandsA study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication
BelgiumStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaLong‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia
NorwayA Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome
BelgiumA study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes
CzechiaA study to evaluate the safety and effectiveness of ANXV in patients with diabetic retinopathy or retinal vein occlusion
GermanyThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
